Cargando…
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
Research in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the organism as a whole. PPARβ/δ activation might help prevent the development of metabolic disorders, i...
Autores principales: | Palomer, Xavier, Barroso, Emma, Pizarro-Delgado, Javier, Peña, Lucía, Botteri, Gaia, Zarei, Mohammad, Aguilar, David, Montori-Grau, Marta, Vázquez-Carrera, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877774/ https://www.ncbi.nlm.nih.gov/pubmed/29558390 http://dx.doi.org/10.3390/ijms19030913 |
Ejemplares similares
-
Endoplasmic reticulum stress downregulates PGC-1α in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2
por: Montori-Grau, Marta, et al.
Publicado: (2022) -
The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance
por: Aguilar-Recarte, David, et al.
Publicado: (2021) -
The Role of Peroxisome Proliferator-Activated Receptor β/δ on the Inflammatory Basis of Metabolic Disease
por: Coll, Teresa, et al.
Publicado: (2010) -
Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes
por: Serrano-Marco, Lucía, et al.
Publicado: (2011) -
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2
por: Barroso, Emma, et al.
Publicado: (2020)